Trials / Completed
CompletedNCT02513862
Prospective Trial of Autologous Platelet Rich Plasma in Aortic Surgery
Prospective Randomized Trial of Autologous Platelet Rich Plasma in Reducing Allogeneic Transfusions During Aortic Surgery Under Deep Hypothermic Circulatory Arrest
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Hongwen Ji · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether autologous platelet rich plasma (APRP)is effective in reducing allogeneic blood transfusions during aortic surgery using deep hypothermic circulatory arrest.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Autologous Platelet-Rich Plasma Harvest Technique | 15 to 20 mL/kg of whole blood is collected before the administration of heparin from a large-bore central venous access,and is separated into red blood cells component and autologous platelet-rich plasma component by an autologous transfusion system(Sorin Group Electa Essential; Sorin Group Italia, Milan, Italy). |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2016-06-01
- Completion
- 2016-10-01
- First posted
- 2015-08-03
- Last updated
- 2016-11-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02513862. Inclusion in this directory is not an endorsement.